Aav

© GettyImages/AlexanderFord

Ocular gene therapy biotech launches with $19M seed funding

By Jane Byrne

This month sees the launch of a new gene therapy player, Opus Genetics, a company backed and spun out by leading patient group Foundation Fighting Blindness’ venture arm, the Retinal Degeneration Fund (RD Fund).

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers